{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:52:19Z","timestamp":1760233939930,"version":"build-2065373602"},"reference-count":59,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T00:00:00Z","timestamp":1615075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001554","name":"Massey University","doi-asserted-by":"publisher","award":["Wenzel Feline Research Fund"],"award-info":[{"award-number":["Wenzel Feline Research Fund"]}],"id":[{"id":"10.13039\/501100001554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>Feline infectious peritonitis (FIP) is a sporadic fatal disease of cats caused by a virulent variant of feline coronavirus (FCoV), referred to as FIP virus (FIPV). Treatment options are limited, and most of the affected cats die or are euthanized. Anecdotally, doxycycline has been used to treat FIP-affected cats, but there are currently no data to support or discourage such treatment. The aim of this study was to establish whether doxycycline inhibits replication of FIPV in vitro. The virus was cultured in Crandell-Rees feline kidney cells with various concentrations of doxycycline (0 to 50 \u00b5g\/mL). The level of FIPV in cultures was determined by virus titration and FCoV-specific reverse-transcription quantitative PCR. Cell viability was also monitored. There was no difference in the level of infectious virus or viral RNA between doxycycline-treated and untreated cultures at 3, 12- and 18-hours post-infection. However, at 24 h, the growth of FIPV was inhibited by approximately two logs in cultures with &gt;10 \u00b5g\/mL doxycycline. This inhibition was dose-dependent, with inhibitory concentration 50% (IC50) 4.1 \u00b5g\/mL and IC90 5.4 \u00b5g\/mL. Our data suggest that doxycycline has some inhibitory effect on FIPV replication in vitro, which supports future clinical trials of its use for the treatment of FIP-affected cats.<\/jats:p>","DOI":"10.3390\/pathogens10030312","type":"journal-article","created":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T21:52:15Z","timestamp":1615153935000},"page":"312","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["In Vitro Effects of Doxycycline on Replication of Feline Coronavirus"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3874-0154","authenticated-orcid":false,"given":"Magdalena","family":"Dunowska","sequence":"first","affiliation":[{"name":"School of Veterinary Science, Massey University, Palmerston North 4410, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayani","family":"Ghosh","sequence":"additional","affiliation":[{"name":"School of Veterinary Science, Massey University, Palmerston North 4410, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,3,7]]},"reference":[{"key":"ref_1","first-page":"1","article-title":"Feline and Canine Coronaviruses: Common Genetic and Pathobiological Features","volume":"2011","year":"2011","journal-title":"Adv. Virol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"D708","DOI":"10.1093\/nar\/gkx932","article-title":"Virus taxonomy: The database of the International Committee on Taxonomy of Viruses (ICTV)","volume":"46","author":"Lefkowitz","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1297-9716-44-57","article-title":"An outbreak of feline infectious peritonitis in a Taiwanese shelter: Epidemiologic and molecular evidence for horizontal transmission of a novel type II feline coronavirus","volume":"44","author":"Wang","year":"2013","journal-title":"Vet. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.tvjl.2014.04.017","article-title":"An update on feline infectious peritonitis: Virology and immunopathogenesis","volume":"201","author":"Pedersen","year":"2014","journal-title":"Vet. J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2460\/ajvr.1995.56.04.429","article-title":"Risk of feline infectious peritonitis in cats naturally infected with feline coronavirus","volume":"56","author":"Addie","year":"1995","journal-title":"Am. J. Vet. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.2460\/javma.1997.210.09.1313","article-title":"Risk factors for feline infectious peritonitis among cats in multiple-cat environments with endemic feline enteric coronavirus","volume":"210","author":"Foley","year":"1997","journal-title":"J. Am. Vet. Med Assoc."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"5123","DOI":"10.1016\/j.vaccine.2020.06.026","article-title":"Vaccination against coronaviruses in domestic animals","volume":"38","author":"Tizard","year":"2020","journal-title":"Vaccine"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.tvjl.2014.04.016","article-title":"An update on feline infectious peritonitis: Diagnostics and therapeutics","volume":"201","author":"Pedersen","year":"2014","journal-title":"Vet. J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jfms.2008.09.008","article-title":"A review of feline infectious peritonitis virus infection: 1963\u20132008","volume":"11","author":"Pedersen","year":"2009","journal-title":"J. Feline Med. Surg."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jfms.2011.01.008","article-title":"Development of monoclonal antibodies (MAbs) to feline interferon (fIFN)-gamma as tools to evaluate cellular immune responses to feline infectious peritonitis virus (FIPV)","volume":"13","author":"Satoh","year":"2011","journal-title":"J. Feline Med. Surg."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fvets.2017.00007","article-title":"Polyprenyl Immunostimulant Treatment of Cats with Presumptive Non-Effusive Feline Infectious Peritonitis in a Field Study","volume":"4","author":"Legendre","year":"2017","journal-title":"Front. Vet. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jfms.2008.12.002","article-title":"Effect of Polyprenyl Immunostimulant on the survival times of three cats with the dry form of feline infectious peritonitis","volume":"11","author":"Legendre","year":"2009","journal-title":"J. Feline Med. Surg."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1111\/j.1939-1676.2011.00806.x","article-title":"Randomized, Placebo Controlled Study of the Effect of Propentofylline on Survival Time and Quality of Life of Cats with Feline Infectious Peritonitis","volume":"25","author":"Fischer","year":"2011","journal-title":"J. Vet. Intern. Med."},{"key":"ref_14","first-page":"1193","article-title":"Effect of feline interferon-omega on the survival time and quality of life of cats with feline infectious peritonitis","volume":"21","author":"Ritz","year":"2007","journal-title":"J. Vet. Intern. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s00705-020-04605-7","article-title":"Therapeutic effect of an anti-human-TNF-alpha antibody and itraconazole on feline infectious peritonitis","volume":"165","author":"Doki","year":"2020","journal-title":"Arch. Virol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the Treatment of Covid-19\u2014Final Report","volume":"383","author":"Beigel","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/1098612X19825701","article-title":"Efficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitis","volume":"21","author":"Pedersen","year":"2019","journal-title":"J. Feline Med. Surg."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1111\/jvim.15780","article-title":"Antiviral treatment using the adenosine nucleoside analogue GS -441524 in cats with clinically diagnosed neurological feline infectious peritonitis","volume":"34","author":"Dickinson","year":"2020","journal-title":"J. Vet. Intern. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.vetmic.2018.04.026","article-title":"The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies","volume":"219","author":"Murphy","year":"2018","journal-title":"Vet. Microbiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1177\/1098612X17729626","article-title":"Efficacy of a 3C-like protease inhibitor in treating various forms of acquired feline infectious peritonitis","volume":"20","author":"Pedersen","year":"2018","journal-title":"J. Feline Med. Surg."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Kim, Y., Liu, H., Galasiti Kankanamalage, A.C., Weerasekara, S., Hua, D.H., Groutas, W.C., Chang, K.-O., and Pedersen, N.C. (2016). Reversal of the Progression of Fatal Coronavirus Infection in Cats by a Broad-Spectrum Coronavirus Protease Inhibitor. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1005531"},{"key":"ref_22","unstructured":"Pedersen, N.C. (2021, March 06). Black Market Production and Sale of GS-441524 and GC376. Available online: https:\/\/ccah.vetmed.ucdavis.edu\/sites\/g\/files\/dgvnsk4586\/files\/inline-files\/Black%20market%20production%20and%20sale%20of%20GS_0.pdf."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1515\/hsz-2013-0292","article-title":"Tetracycline antibiotics and resistance mechanisms","volume":"395","author":"Nguyen","year":"2014","journal-title":"Biol. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/bph.12139","article-title":"Minocycline: Far beyond an antibiotic","volume":"169","author":"Zarzuelo","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"C539","DOI":"10.1152\/ajpcell.00047.2010","article-title":"Tetracyclines: A pleitropic family of compounds with promising therapeutic properties. Review of the literature","volume":"299","author":"Griffin","year":"2010","journal-title":"Am. J. Physiol. Physiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/bcpt.12444","article-title":"Is Minocycline an Antiviral Agent? A Review of Current Literature","volume":"118","author":"Nagarakanti","year":"2015","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Li, Y., Wu, Z., Liu, K., Qi, P., Xu, J., Wei, J., Li, B., Shao, D., Shi, Y., and Qiu, Y. (2017). Doxycycline enhances adsorption and inhibits early-stage replication of porcine reproductive and respiratory syndrome virus in vitro. FEMS Microbiol. Lett., 364.","DOI":"10.1093\/femsle\/fnx170"},{"key":"ref_28","first-page":"681","article-title":"Study the antiviral activity of some derivatives of tetracycline and non-steroid anti inflammatory drugs towards dengue virus","volume":"30","author":"Rothan","year":"2013","journal-title":"Trop. Biomed."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00705-013-1880-7","article-title":"Inhibitory effect of doxycycline against dengue virus replication in vitro","volume":"159","author":"Rothan","year":"2014","journal-title":"Arch. Virol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1358\/mf.1998.20.8.487489","article-title":"Antimurine retroviral effect of doxycycline","volume":"20","author":"Sturtz","year":"1998","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Wu, Z.C., Wang, X., Wei, J.-C., Li, B.B., Shao, D.-H., Li, Y.-M., Liu, K., Shi, Y.-Y., Zhou, B., and Qiu, Y.-F. (2015). Antiviral activity of doxycycline against vesicular stomatitis virus In Vitro. FEMS Microbiol. Lett., 362.","DOI":"10.1093\/femsle\/fnv195"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1139\/cjpp-2015-0481","article-title":"Doxycycline inhibits proliferation and induces apoptosis of both human papillomavirus positive and negative cervical cancer cell lines","volume":"94","author":"Zhao","year":"2016","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Gendrot, M., Andreani, J., Jardot, P., Hutter, S., Delandre, O., Boxberger, M., Mosnier, J., Le Bideau, M., Duflot, I., and Fonta, I. (2020). In Vitro Antiviral Activity of Doxycycline against SARS-CoV-2. Molecules, 25.","DOI":"10.3390\/molecules25215064"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Rothan, H.A., Bahrani, H., Mohamed, Z., Teoh, T.C., Shankar, E.M., Rahman, N.A., and Yusof, R. (2015). A Combination of Doxycycline and Ribavirin Alleviated Chikungunya Infection. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0126360"},{"key":"ref_35","first-page":"1","article-title":"Modulation of Cytokine and Cytokine Receptor\/Antagonist by Treatment with Doxycycline and Tetracycline in Patients with Dengue Fever","volume":"2011","author":"Castro","year":"2011","journal-title":"Clin. Dev. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/imm.12246","article-title":"Minocycline attenuates HIV-1 infection and suppresses chronic immune activation in humanized NOD\/LtsZ-scidIL-2Rgamma (null) mice","volume":"142","author":"Singh","year":"2014","journal-title":"Immunology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.293.16.2003","article-title":"Neuroprotective and Anti\u2013Human Immunodeficiency Virus Activity of Minocycline","volume":"293","author":"Zink","year":"2005","journal-title":"JAMA"},{"key":"ref_38","first-page":"7460","article-title":"Doxycycline attenuates acute lung injury following cardiopulmonary bypass: Involvement of matrix met-alloproteinases","volume":"7","author":"Wang","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.3892\/mmr.2015.3833","article-title":"Doxycycline inhibits leukemic cell migration via inhibition of matrix metalloproteinases and phosphorylation of focal adhesion kinase","volume":"12","author":"Wang","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/0363546509347366","article-title":"Doxycycline-Mediated Inhibition of Matrix Metalloproteinases Improves Healing after Rotator Cuff Repair","volume":"38","author":"Bedi","year":"2010","journal-title":"Am. J. Sports Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1749-6632.1994.tb24776.x","article-title":"The in Vivo Effect of Doxycycline Treatment on Matrix Metalloproteinases in Reactive Arthritis","volume":"732","author":"Lauhio","year":"1994","journal-title":"Ann. New York Acad. Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1128\/AAC.00594-16","article-title":"rRNA Binding Sites and the Molecular Mechanism of Action of the Tetracyclines","volume":"60","author":"Chukwudi","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2885.1990.tb00797.x","article-title":"Comparative pharmacokinetics of doxycycline in cats and dogs","volume":"13","author":"Riond","year":"1990","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2885.2007.00932.x","article-title":"Pharmacokinetics of pradofloxacin and doxycycline in serum, saliva, and tear fluid of cats after oral administration","volume":"31","author":"Hartmann","year":"2008","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3390\/v4060980","article-title":"Recent Progress in Studies of Arterivirus- and Coronavirus-Host Interactions","volume":"4","author":"Zhong","year":"2012","journal-title":"Viruses"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/tbed.13081","article-title":"Circulation and genetic diversity of Feline coronavirus type I and II from clinically healthy and FIP-suspected cats in China","volume":"66","author":"Li","year":"2019","journal-title":"Transbound Emerg. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1089\/omi.2020.0071","article-title":"In silico Potential of Approved Antimalarial Drugs for Repurposing Against COVID-19","volume":"24","author":"Sachdeva","year":"2020","journal-title":"OMICS: A J. Integr. Biol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Sencanski, M., Perovic, V., Pajovic, S.B., Adzic, M., Paessler, S., and Glisic, S. (2020). Drug Repurposing for Candidate SARS-CoV-2 Main Protease Inhibitors by a Novel in Silico Method. Molecules, 25.","DOI":"10.26434\/chemrxiv.12248561"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Ahler, E., Sullivan, W.J., Cass, A., Braas, D., York, A.G., Bensinger, S.J., Graeber, T.G., and Christofk, H.R. (2013). Doxycycline Alters Metabolism and Proliferation of Human Cell Lines. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0064561"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Luger, A.-L., Sauer, B., Lorenz, N.I., Engel, A.L., Braun, Y., Voss, M., Harter, P.N., Steinbach, J.P., and Ronellenfitsch, M.W. (2018). Doxycycline Impairs Mitochondrial Function and Protects Human Glioma Cells from Hypoxia-Induced Cell Death: Implications of Using Tet-Inducible Systems. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19051504"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.stemcr.2014.06.013","article-title":"Doxycycline Enhances Survival and Self-Renewal of Human Pluripotent Stem Cells","volume":"3","author":"Chang","year":"2014","journal-title":"Stem Cell Rep."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e00864","DOI":"10.1016\/j.idcr.2020.e00864","article-title":"Doxycycline as a potential partner of COVID-19 therapies","volume":"21","author":"Malek","year":"2020","journal-title":"IDCases"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00705-020-04860-8","article-title":"Tetracycline and viruses: A possible treatment for COVID-19?","volume":"166","year":"2021","journal-title":"Arch. Virol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"198197","DOI":"10.1016\/j.virusres.2020.198197","article-title":"The role of dysregulated immune responses in COVID-19 pathogenesis","volume":"290","author":"Zafari","year":"2020","journal-title":"Virus Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1753466620951053","DOI":"10.1177\/1753466620951053","article-title":"Doxycycline treatment of high-risk COVID-19-positive patients with comorbid pulmonary disease","volume":"14","author":"Yates","year":"2020","journal-title":"Ther. Adv. Respir. Dis."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Ghosh, S., and Malik, Y.S. (2020). Drawing Comparisons between SARS-CoV-2 and the Animal Coronaviruses. Microorganisms, 8.","DOI":"10.3390\/microorganisms8111840"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nri1732","article-title":"Immunopathogenesis of coronavirus infections: Implications for SARS","volume":"5","author":"Dandekar","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"ref_58","first-page":"493","article-title":"A simple method of estimating fifty percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Hyg."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0165-022X(00)00129-9","article-title":"Effect of experimental treatment on housekeeping gene expression: Validation by re-al-time, quantitative RT-PCR","volume":"46","author":"Schmittgen","year":"2000","journal-title":"J. Biochem. Biophys. Methods"}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/10\/3\/312\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:34:24Z","timestamp":1760160864000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/10\/3\/312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,7]]},"references-count":59,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3]]}},"alternative-id":["pathogens10030312"],"URL":"https:\/\/doi.org\/10.3390\/pathogens10030312","relation":{},"ISSN":["2076-0817"],"issn-type":[{"type":"electronic","value":"2076-0817"}],"subject":[],"published":{"date-parts":[[2021,3,7]]}}}